SINGLE STEP
DEAD

Serial Number

88281045

Owner

Essenlix Corporation

Attorney

Xiongying Tu

Filing Date

Jan 29, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SINGLE STEP Trademark

Serial Number: 88281045

SINGLE STEP is a trademark filed by Essenlix Corporation on January 29, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Essenlix Corporation (147 trademarks)

7 Foulet Dr
Princeton, CA 08540

Entity Type: 03

Trademark Details

Filing Date

January 29, 2019

Registration Date

Not Registered

Published for Opposition

June 10, 2025

Goods & Services

Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes; Biological and chemical testing kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for the detection of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Medical diagnostic instruments for the analysis of body fluids in the nature of biological and chemical test kits for the detection and identification of nucleic acids, namely DNA and RNA in a sample; all of the aforesaid not including blood sampling prickers and parts therefore, and injection needles for use with glass ampoules

Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; all of the aforesaid not including cell culture medium and chemical preparation and reagent, for medical and veterinary use

Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services in the field of digital healthcare services; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing, diagnostic testing, and wellness services, all in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample; all of the foresaid not in the nature of providing health information in the field of mental health and addiction and providing a website featuring information about health and wellness, namely, trauma, sadness, depression, addiction, and behavioral ailments

Assays for research purposes; Biological and chemical reagents used for non-medical research or laboratory purposes, namely, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, and diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory or research use; all of the aforesaid not including cell culture medium and chemical preparation and reagent, for scientific and diagnostic or laboratory research use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 11, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 11, 2026 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 3, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 3, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 3, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 3, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 3, 2026 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 7, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 10, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 10, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 4, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 12, 2025 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 2, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 1, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 1, 2024 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 1, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 30, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 30, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 31, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 29, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 29, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 29, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 27, 2020 RCSC
ASSIGNED TO EXAMINER
Jul 30, 2020 DOCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 27, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 25, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 25, 2019 GNSL
SUSPENSION LETTER WRITTEN
Oct 25, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 16, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 16, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 16, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 16, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 8, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 21, 2019 NWOS
NEW APPLICATION ENTERED
Feb 1, 2019 NWAP